EDN1 and endothelial dysfunction: Plasma levels of ET‐1 and the relatively stable big ET‐1 and CT‐proET‐1 (a fragment of the ET‐1 precursor) are increased in HF and predict outcome.5, 6, 7 Changes in plasma biomarkers of ET‐1 synthesis may be expected to indicate endothelial dysfunction.